Oncology · Urologic Oncology
The facts most likely to be tested
Painless gross hematuria in an older adult is the classic presentation of bladder cancer until proven otherwise.
Cigarette smoking is the single most significant and modifiable risk factor for the development of urothelial (transitional cell) carcinoma.
Occupational exposure to aromatic amines (e.g., rubber, dye, textile, or petroleum industries) is a high-yield secondary risk factor.
Cystoscopy with biopsy is the gold standard diagnostic procedure for definitive diagnosis and staging of bladder lesions.
Urine cytology is a highly specific but low-sensitivity screening test often used as an adjunct to cystoscopy.
Bacillus Calmette-Guérin (BCG) vaccine intravesical therapy is the standard treatment for high-risk non-muscle-invasive bladder cancer to prevent recurrence.
Radical cystectomy with urinary diversion is the definitive treatment for muscle-invasive bladder cancer.
Vignette unlocked
A 68-year-old male presents to the clinic complaining of painless gross hematuria that has occurred intermittently over the past three weeks. He has a 40-pack-year smoking history and worked for 30 years in a chemical manufacturing plant. Physical examination is unremarkable, and a urinalysis confirms hematuria without evidence of infection or casts. A CT urogram shows no upper tract abnormalities.
What is the most appropriate next step in the management of this patient?
Cystoscopy with biopsy
The patient presents with classic risk factors and symptoms for bladder cancer; cystoscopy is the gold standard for direct visualization and tissue sampling to confirm the diagnosis.
Full handout
High yield triage
Etiology / Epidemiology
Predominantly smoking and occupational exposure (aromatic amines). Most common histology is urothelial (transitional cell) carcinoma.
Clinical Manifestations
Classic presentation is painless gross hematuria. Painless hematuria is the board-favorite buzzword.
Diagnosis
Gold standard is cystoscopy with biopsy. Initial imaging is often CT urography.
Treatment
Superficial disease treated with transurethral resection of bladder tumor (TURBT) and intravesical BCG.
Prognosis
High rate of recurrence requires lifelong surveillance cystoscopy.
Full handout
Epidemiology & Etiology
Bladder cancer is the most common malignancy of the urinary tract, with a 3:1 male-to-female ratio. Smoking is the single most significant risk factor, accounting for 50% of cases. Occupational exposure to aromatic amines (dyes, rubber, textiles) is a classic board association.
Pertinent Anatomy
The bladder is lined by urothelium (transitional epithelium) extending from the renal pelvis to the proximal urethra. Tumors most commonly arise in the bladder trigone or lateral walls.
Pathophysiology
Chronic irritation or carcinogen exposure leads to malignant transformation of the urothelium. The disease follows a spectrum from papillary non-invasive lesions to muscle-invasive carcinoma. The field cancerization effect explains why patients are at risk for synchronous or metachronous tumors throughout the urinary tract.
Clinical Manifestations
The hallmark is painless gross hematuria in an older adult. Irritative voiding symptoms (frequency, urgency, dysuria) may mimic a UTI but fail to resolve with antibiotics. Flank pain or suprapubic mass suggests advanced, muscle-invasive disease.
Diagnosis
The gold standard for diagnosis and staging is cystoscopy with biopsy. CT urography is the preferred imaging modality to evaluate the upper urinary tract for synchronous lesions. Urine cytology has high specificity but low sensitivity for low-grade tumors.
Treatment
For non-muscle invasive disease, TURBT is the primary treatment. Intravesical BCG (Bacillus Calmette-Guérin) is the first-line adjuvant therapy to prevent recurrence. Contraindications for BCG include immunosuppression or active gross hematuria. Muscle-invasive disease requires radical cystectomy.
Prognosis
Bladder cancer has a high recurrence rate, necessitating frequent surveillance cystoscopy. Patients are at risk for upper tract urothelial carcinoma, requiring periodic imaging of the kidneys and ureters.
Differential Diagnosis
Nephrolithiasis: typically presents with severe, colicky flank pain
UTI: usually associated with fever, pyuria, and positive urine culture
BPH: hematuria is usually microscopic and associated with obstructive voiding symptoms
Renal Cell Carcinoma: classic triad of hematuria, flank pain, and palpable mass
Prostate Cancer: usually presents with obstructive symptoms or elevated PSA